Improvement (greater than 50% of time spent) heel‐toe walking Measured by parents' perception of toe walking frequency more than 50% of the time. · children with ITW gait
It is very uncertain whether botulinum toxin plus conservative treatment changes improvement (greater than 50% of time spent) heel‐toe walking… compared with conservative treatment only (very low certainty).
1 finding from 1 review
Recurrence of ITW post‐treatment Assessed by improvement in toe walking based on Gait Analysis Classification An increase indicates improvement (an improvement indicated by a change in downgrading of the severe or 3, moderate or 2, and mild or 1 c... · children with ITW gait
1 finding from 1 review
Time spent walking (minutes per week, activity monitor) · people with NMD
3 findings from 1 review
no estimate extracted
1 study · 69 participants
Low
no estimate extracted
1 study · 74 participants
Low
no estimate extracted
1 study · 70 participants
Low
Time spent walking (minutes per week, activity monitor) · people with NMD
1 finding from 1 review
Time from randomisation until recovery of unaided walking · patients with Guillain‐Barré syndrome
1 finding from 1 review
Time from randomisation until recovery of unaided walking · patients with Guillain‐Barré syndrome
1 finding from 1 review
Time from randomisation until recovery of unaided walking · patients with Guillain‐Barré syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time from randomisation until recovery of unaided walking · patients with Guillain‐Barré syndrome
1 finding from 1 review
Time from randomisation until recovery of unaided walking · adults with severe Guillain‐Barré syndrome (GBS disability score > 2), within 2 weeks form onset
1 finding from 1 review
no estimate extracted
1 study · 7 participants
Low
Change from baseline in 6MWT (metres) · children and adults with SMA type 3
1 finding from 1 review
Walking with aid at 4 weeks · patients with Guillain‐Barré syndrome
Plasma exchange probably leads to higher walking with aid at 4 weeks compared with sham exchange or supportive treatment (moderate certainty).
1 finding from 1 review
Change in 10‐metre walking time · patients with Duchenne muscular dystrophy
1 finding from 1 review
Change in 10‐metre walking time · patients with Duchenne muscular dystrophy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Nine‐metre walking/running time: prednisone ‐ daily dose regimen (0.75 mg/kg/day) · patients with Duchenne muscular dystrophy
1 finding from 1 review
Active range of motion of the ankle joint · children with ITW gait
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change from baseline in passive ankle dorsiflexion range of movement · children with ITW gait
1 finding from 1 review
Pain · children with ITW gait
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · children with ITW gait
It is very uncertain whether botulinum toxin plus conservative treatment changes adverse events compared with conservative treatment only (very low certainty).
1 finding from 1 review